Medpace Holdings, Inc. (FRA:01P)

Market Cap	12.39B +54.4%
Revenue (ttm)	2.16B +20.0%
Net Income	384.22M +11.6%
EPS	13.01 +21.0%
Shares Out	n/a
PE Ratio	32.25
Forward PE	28.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58
Average Volume	4
Open	362.30
Previous Close	432.30
Day's Range	330.40 - 362.30
52-Week Range	249.10 - 558.20
Beta	n/a
RSI	26.51
Earnings Date	Apr 22, 2026

About Medpace Holdings

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data man...

• Industry: Commercial Physical and Biological Research
• Founded: 1992
• Employees: 6,200
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 01P

Financial Performance

In 2025, Medpace Holdings's revenue was $2.53 billion, an increase of 19.97% compared to the previous year's $2.11 billion. Earnings were $451.12 million, an increase of 11.57%.

Financial numbers in USD